Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD 3.600
-0.020 (-0.55%)
Oct 9, 2026, 4:08 PM HKT
HKG:2591 Revenue
Guangzhou Innogen Pharmaceutical Group had revenue of 78.22M CNY in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 153.28M, up 171.55% year-over-year. In the year 2025, Guangzhou Innogen Pharmaceutical Group had annual revenue of 131.51M. That makes Guangzhou Innogen Pharmaceutical Group the 33,074th largest company in the world by revenue and 1,997th in Hong Kong.
Revenue (ttm)
153.28M CNY
Revenue Growth
+171.55%
P/S Ratio
9.29
Revenue / Employee
716.27K CNY
Employees
214
Market Cap
1.64B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 131.51M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.